Cargando…
A taRNA vaccine candidate induces a specific immune response that protects mice against Chikungunya virus infections
The arthritogenic alphavirus, chikungunya virus (CHIKV), is now present in almost 100 countries worldwide. Further spread is very likely, which raises public health concerns. CHIKV infections cause fever and arthralgia, which can be debilitating and last for years. Here, we describe a CHIKV vaccine...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Gene & Cell Therapy
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126847/ https://www.ncbi.nlm.nih.gov/pubmed/35664702 http://dx.doi.org/10.1016/j.omtn.2022.04.036 |